Skip to main content
. 2021 Mar 1;16(1):86–94. doi: 10.1007/s11764-021-01006-w

Fig. 2.

Fig. 2

Cumulative 10-year prostate cancer follow-up cost distribution by initial treatment type for (I) perspective and (II) resource use